Table 3.
Overview of characteristics of included documents
| Characteristic | Output |
|---|---|
| Year | Last 8 y (2010‐2018) (n = 69) |
| 10 y (2000‐2010) (n = 22) | |
| Focus | Clinical trial (n = 24) |
| Health research (n = 47) | |
| Regulation and HTA (n = 8) | |
| Other (n = 12) | |
| Country of origin | Canada (n = 11) |
| United Kingdom (n = 40) | |
| Canada and the United Kingdom (n = 1) | |
| United States (n = 27) | |
| Europe (n = 6) | |
| Netherlands (n = 4) | |
| Germany (n = 1) | |
| Denmark (n = 1) | |
| Setting | Academia (n = 38) |
| Health care (n = 19) | |
| Industry (n = 3) | |
| Mixed (n = 14) | |
| Other (n = 17) | |
| Methodology (academic literature only) | Quantitative study (n = 6) |
| Qualitative study (n = 23) | |
| Mixed method study (n = 15) | |
| Literature review (n = 25) | |
| Commentary/Editorial/Opinion/other (n = 8) | |
| Patients involved as partners in the study (academic literature only) | Yes (n = 16) |
| Unspecified (n = 61) |